US officials barred from trial of American in China linked to GSK investigation
Related Blog Posts
- Sunday Times: Sex tape ignited GSK's China scandal
- GSK to pay $105M, including $2.5M to NC, for 'improper drug marketing'
- Reports: GSK in $350M deal to develop cancer drugs
- GSK faces UK 'criminal investigation' into commercial practices
- China accuses GSK executive of operating 'massive bribery network'
- GSK's CEO remains bullish despite 18% drop in earnings
- Glaxo CEO: Major deals to 'improve long-term earnings'
- GSK acknowledges more employee bribery allegations
- GSK launches probe into Iraq bribery claims
BEIJING — U.S. diplomats will be barred from the trial in China of an American investigator for GlaxoSmithKline (NYSE: GSK) and her British husband who are charged with improperly selling personal information, according to a spokesman for the U.S. Embassy in Beijing.
The arrest of Yu Yingzeng and husband Peter Humphrey last year coincided with a Chinese investigation of accusations British pharmaceutical company GlaxoSmithKline paid bribes to doctors and officials to use its medications.
Glaxo said it hired Yu and Humphrey last year to investigate a security breach involving a top manager.
The Sunday Times reported that several top executives at the company received anonymous emails about the bribery allegations as well as a secretly recorded video of the firm's general manager in China, Mark Reilly, having sex with his girlfriend. The report said the company suspected a former employee was behind the emails.
U.S. Embassy spokesman Nolan Barkhouse on Friday expressed concern diplomats would be barred from the August trial. He gave no reason for the ban.
Barkhouse said consular officials are permitted to attend such trials under a 1982 agreement between China and the U.S. He said diplomats had been allowed to visit Yu as recently as Wednesday.
A British Embassy official in Beijing declined to say whether its diplomats would be allowed to attend the trial but said British officials were talking to their Chinese counterparts about the issue.
Reilly has been detained by Chinese authorities on charges he had GlaxoSmithKline salespeople pay millions of dollars in bribes to doctors, hospital administrators and others to encourage use of its drugs. Four Chinese employees also have been detained and a police official said in May that dozens of people were implicated, though he gave no details.
Humphrey, a former reporter with the Reuters news agency, and Yu ran the Shanghai-based corporate intelligence and consulting firm ChinaWhys Ltd.
Last year, the Shanghai police department said several dozen reports prepared by them for corporate clients contained information that "seriously violated the legitimate rights of citizens."
That included home addresses and information on family members, real estate and vehicles, police said. They were sold to clients including manufacturers, law firms and financial institutions.
In August, Humphrey was shown handcuffed on Chinese state television apologizing to the government that they "obtained personal information, sometimes through illegal ways."
[GSK operates its North American headquarters in Research Triangle Park, N.C.]
Please Log In to add a comment.
Best of TechWire Insider
- N.C. Senate gives tentative OK to bill including crowdfunding
- Crowdfunding bill moves - again - as part of different legislation
- AT&T already seeking permits for rollout of ultrafast network
- Latest stats show institutional venture capital in N.C. becoming a joke
- With cities on board, N.C. Next Generation Network is rolling toward first big deployment target
- Is IBM-Apple deal a slap in the face for Lenovo?
- A rare look into economic recruitment, requirements: Cary's disappearing 1,237 jobs document
- N.C. Senate committee to consider crowdfunding bill
- NCTA renames its '21 Awards,' to honor winners with 'Beacon'
- Vivek Wadhwa's book 'Innovating Women' hits markets Sept. 2